US Stock MarketDetailed Quotes
KTTA Pasithea Therapeutics
- 3.8000
- +0.0050+0.13%
Close Nov 1 16:00 ET
- 3.8000
- 0.00000.00%
Post 20:02 ET
3.97MMarket Cap-256P/E (TTM)
3.8000High3.6300Low21.36KVolume3.7500Open3.7950Pre Close79.63KTurnover2.66%Turnover RatioLossP/E (Static)1.04MShares17.400052wk High0.25P/B3.05MFloat Cap3.400052wk Low--Dividend TTM803.29KShs Float170.0000Historical High--Div YieldTTM4.48%Amplitude3.4000Historical Low3.7290Avg Price1Lot Size
Pasithea Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -31.15%-4.04M | -34.94%-4.32M | -7.73%-12.81M | -3.42%-3.29M | 29.94%-3.24M | -59.12%-3.08M | -48.79%-3.2M | -274.74%-11.89M | -82.61%-3.19M | -742.68%-4.62M |
| Net income from continuing operations | -7.45%-3.87M | -18.22%-3.86M | -32.23%-15.51M | -24.12%-5.03M | 13.80%-3.61M | -64.31%-3.6M | -152.46%-3.27M | -439.58%-11.73M | -743.25%-4.05M | -174.62%-4.19M |
| Operating gains losses | 119.96%35.62K | -157.00%-26.72K | 93.45%-121.29K | 105.64%55.31K | -113.42%-45K | 57.68%-178.47K | 105.97%46.87K | 20.66%-1.85M | 62.09%-980.51K | --335.32K |
| Depreciation and amortization | -0.00%162.26K | 0.33%162.26K | 12,629.76%648.45K | 3,820.28%162.22K | 16,225,700.00%162.26K | 16,854.75%162.26K | --161.72K | 269.40%5.09K | 200.07%4.14K | ---1 |
| Other non cash items | ---- | ---- | ---- | ---- | --960 | --960 | 96,100.00%960 | ---- | ---- | ---- |
| Change In working capital | -268.69%-531.45K | -191.69%-942.26K | 86.22%1.57M | -13.97%1.45M | 117.32%129.85K | 171.95%315.04K | -54.63%-323.04K | 659.97%845.35K | 3,028.64%1.69M | -132.72%-749.8K |
| -Change in receivables | ---- | --0 | ---- | ---- | ---- | ---- | ---15.78K | ---- | ---- | ---- |
| -Change in prepaid assets | 2,107.89%468.16K | -200.84%-822.51K | 291.03%346.48K | 57.54%769.17K | 67.94%-170.49K | -78.95%21.2K | -14.65%-273.4K | 44.95%-181.37K | 262.27%488.25K | -34.44%-531.87K |
| -Change in payables and accrued expense | -322.39%-1.04M | -249.64%-118.37K | 43.61%1.07M | 143.76%682.9K | -111.18%-45.34K | 1,437.84%467.26K | -214.56%-33.86K | 69.23%745.76K | 446.66%280.15K | 452.57%405.67K |
| -Change in other current assets | 121.40%40.5K | --58 | 160.19%158.29K | -99.50%1.8K | 160.15%345.68K | ---189.2K | --0 | ---262.99K | --358.29K | ---574.68K |
| -Change in other current liabilities | ---963 | ---1.45K | -100.28%-1.55K | -100.28%-1.55K | --0 | --0 | --0 | --543.96K | --561.52K | ---48.91K |
| Cash from discontinued investing activities | 0 | 0 | -3,836.11%-399.69K | 55.39%-183.44K | ||||||
| Operating cash flow | -16.08%-4.04M | -27.63%-4.32M | -7.73%-12.81M | -3.42%-3.29M | 37.11%-2.65M | -80.77%-3.48M | -32.08%-3.39M | -274.74%-11.89M | -82.61%-3.19M | -669.64%-4.22M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 103.27%75.2K | 102.33%54.54K | 293.16%50.16K | -65.21%24.39K | -2,662.07%-53.89K | -10,594.78%-2.3M | -18,007.96%-2.34M | -203.00%-25.97K |
| Net PPE purchase and sale | --0 | --0 | 67.97%-34.3K | 100.04%36 | 513.03%22.66K | 55.21%-3.11K | -2,662.07%-53.89K | -398.07%-107.1K | -616.96%-92.73K | 35.99%-5.49K |
| Net business purchase and sale | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---2.19M | ---2.25M | ---20.48K |
| Net other investing changes | ---- | ---- | --109.5K | --54.5K | --27.5K | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | 113.63%399.01K | 102.40%54.54K | 126.98%50.16K | 194.99%344.01K | 54.19%-49.7K | -13,510.18%-2.93M | -17,452.08%-2.27M | -2,069.45%-185.92K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | -16.22%-3.73M | 0 | -3.86M | -130.77K | 264.1K | -105.73%-3.21M | -109.38%-3.21M | 0 |
| Net issuance payments of debt | --0 | --0 | --0 | --0 | ---133.34K | ---130.77K | --264.1K | --0 | --0 | --0 |
| Net common stock issuance | ---- | ---- | -16.22%-3.73M | --0 | ---- | ---- | ---- | -106.38%-3.21M | -111.80%-3.21M | ---- |
| Cash from discontinued financing activities | 65.98%-611.28K | 97.80%-16.9K | -1.8M | -769.68K | -1.03M | |||||
| Financing cash flow | --0 | --0 | 13.30%-4.34M | 99.58%-16.9K | -333.74%-4.45M | ---130.77K | --264.1K | -108.94%-5M | -111.64%-3.98M | -105.00%-1.03M |
| Net cash flow | ||||||||||
| Beginning cash position | -59.85%12.01M | -50.64%16.33M | -37.45%33.09M | -53.79%19.58M | -44.36%26.65M | -40.44%29.91M | -37.45%33.09M | 21,612.28%52.9M | 106.07%42.38M | 8,317.88%47.9M |
| Current changes in cash | -23.66%-4.04M | -36.26%-4.32M | 15.49%-16.75M | 65.47%-3.26M | -29.90%-7.06M | -42.82%-3.27M | -18.69%-3.17M | -137.59%-19.82M | -129.10%-9.43M | -127.17%-5.43M |
| Effect of exchange rate changes | -818.61%-2.91K | 75.03%-620 | -140.31%-3.99K | -97.80%3.07K | 94.84%-4.26K | 99.25%-317 | 44.98%-2.48K | 193.74%9.9K | 2,150.61%139.42K | -5,590.69%-82.52K |
| End cash Position | -70.10%7.97M | -59.85%12.01M | -50.64%16.33M | -50.64%16.33M | -53.79%19.58M | -44.36%26.65M | -40.44%29.91M | -37.53%33.09M | -37.53%33.09M | 106.07%42.38M |
| Free cash flow | -15.98%-4.04M | -25.63%-4.32M | -7.06%-12.85M | -0.49%-3.29M | 37.73%-2.63M | -80.28%-3.48M | -34.08%-3.44M | -275.57%-12M | -86.55%-3.28M | -658.79%-4.23M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data